New England Securities’s iShares US Pharmaceuticals ETF IHE Stock Holding History

New England Securities’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$955K	Buy	18,933 +4,911	+35%	+$239K	0.34%	67
2014 Q3	$656K	Sell	14,022 -1,752	-11%	-$79.1K	0.23%	107
2014 Q2	$710K	Buy	15,774 +2,019	+15%	+$86.8K	0.25%	104
2014 Q1	$581K	Sell	13,755 -4,548	-25%	-$191K	0.22%	115
2013 Q4	$721K	Buy	18,303 +3,798	+26%	+$142K	0.3%	82
2013 Q3	$514K	Buy	14,505 +2,958	+26%	+$104K	0.26%	101
2013 Q2	$384K	Buy	+11,547	New	+$384K	0.26%	95

Other funds holding IHE

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

AWA

ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return

BCM

Brookstone Capital Management Wheaton, Illinois $9.99B AUM 23.61% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

BWM

Braver Wealth Management Needham, Massachusetts $616M AUM 12.48% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

New England Securities's IHE Position: Q4 2014 in Review

New England Securities increased its iShares US Pharmaceuticals ETF (IHE) stake by 35% in Q4 2014, buying an estimated $239K and bringing the position to 18,933 shares worth $955K. The position accounts for 0.34% of the portfolio, ranked #67.

New England Securities first reported a position in IHE in Q2 2013 and has held it in 7 quarters since. 102 funds tracked by Wall St. Rank hold IHE as of Q4 2014.

New England Securities held 18,933 shares of iShares US Pharmaceuticals ETF worth $955K as of Q4 2014.
New England Securities bought 4,911 iShares US Pharmaceuticals ETF shares in Q4 2014, an estimated $239K.
iShares US Pharmaceuticals ETF made up 0.34% of New England Securities's portfolio in Q4 2014, its #67 holding.
New England Securities first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and has held it in 7 quarters since.
102 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.